616450 Sigma-AldrichTGF-β1, Human Platelets
Produits recommandés
Aperçu
| Replacement Information |
|---|
Tableau de caractéristiques principal
| Purity |
|---|
| ≥97% by SDS-PAGE |
| Product Information | |
|---|---|
| Form | Lyophilized |
| Formulation | Lyophilized from a sterile-filtered solution of 50 µg BSA/µg TGF-β1, 35% acetonitrile, 0.1% TFA. |
| Quality Level | MQ100 |
| Applications |
|---|
| Physicochemical Information | |
|---|---|
| Contaminants | Endotoxin: ≤1 EU/ug of TGF-β1 |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Référence | GTIN |
| 616450 | 0 |
Documentation
Required Licenses
| Title |
|---|
| PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD |
TGF-β1, Human Platelets FDS
| Titre |
|---|
TGF-β1, Human Platelets Certificats d'analyse
| Titre | Numéro de lot |
|---|---|
| 616450 |
Références bibliographiques
| Aperçu de la référence bibliographique |
|---|
| Lomo, J., et al. 1995. J. Immunol. 154, 1634. Marushige, K. and Marushige, Y. 1995. Anticancer Res. 14, 2419. Bermundez, L.E. 1993. J. Immunol. 150, 1838. Hamilton, J.A., et al. 1993. J. Immunol. 150, 1496. Reilly, J.T., et al. 1993. Br. J. Haematol. 83, 58. Sporn, M.B. and Roberts, A.B. 1993. Growth Factors 8, 1. |



